SESSION TITLE: Lung Cancer I
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: A number of randomized controlled trials have observed an efficacy of chemotherapy (CT) plus COX-2 inhibitor versus CT alone in previously untreated locally non-small cell lung cancer (NSCLC). We carried out a systematic review and meta-analysis (MA) of CT plus COX-2 inhibitor in people and mice.